CILOSTAZOL

Product NDC
84386-002
11-digit product format
843860002
Labeler code
84386
Product ID
84386-002_7c841eed-a98f-43c3-baaf-bf5502207a69
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
CILOSTAZOL
Dosage form
TABLET
Route
ORAL
Labeler
Aurobindo Pharma Limited
Application
ANDA077019
Marketing category
ANDA
Marketing start
2026-09-03
Substance
CILOSTAZOL
Active strength
50 mg/1
Pharmacologic classes
Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A077019-001CILOSTAZOLCILOSTAZOL50MGTABLET / ORALAB2004-11-23
A077019-002CILOSTAZOLCILOSTAZOL100MGTABLET / ORALAB2004-11-23

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-productTE code
A077019-001AB
A077019-002AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 88 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-10-15 13:18:302026-09A077019-001CILOSTAZOL50MGTABLET / ORALAB2004-11-23c2088c7a36db…
2026-10-15 13:18:302026-09A077019-002CILOSTAZOL100MGTABLET / ORALAB2004-11-23c2088c7a36db…
2026-09-14 22:38:342026-08A077019-001CILOSTAZOL50MGTABLET / ORAL2004-11-2384e616aacf4f…
2026-09-14 22:38:342026-08A077019-002CILOSTAZOL100MGTABLET / ORAL2004-11-2384e616aacf4f…
2026-08-18 06:07:402026-07A077019-001CILOSTAZOL50MGTABLET / ORAL2004-11-23caaa826d4ba7…
2026-08-18 06:07:402026-07A077019-002CILOSTAZOL100MGTABLET / ORAL2004-11-23caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A077019-001CILOSTAZOL50MGTABLET / ORAL2004-11-23011fe1cb6892…
2026-02-19 14:30 UTC2026-02A077019-002CILOSTAZOL100MGTABLET / ORAL2004-11-23011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A077019-001CILOSTAZOL50MGTABLET / ORAL2004-11-2331067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A077019-002CILOSTAZOL100MGTABLET / ORAL2004-11-2331067a03dcf5…
2025-08-23 18:47 UTC2025-08A077019-001CILOSTAZOL50MGTABLET / ORAL2004-11-236a471c1ec25d…
2025-08-23 18:47 UTC2025-08A077019-002CILOSTAZOL100MGTABLET / ORAL2004-11-236a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A077019-001CILOSTAZOL50MGTABLET / ORAL2004-11-23fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A077019-002CILOSTAZOL100MGTABLET / ORAL2004-11-23fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A077019-001CILOSTAZOL50MGTABLET / ORAL2004-11-23b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A077019-002CILOSTAZOL100MGTABLET / ORAL2004-11-23b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A077019-001CILOSTAZOL50MGTABLET / ORAL2004-11-2303ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A077019-002CILOSTAZOL100MGTABLET / ORAL2004-11-2303ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A077019-001CILOSTAZOL50MGTABLET / ORAL2004-11-232680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A077019-002CILOSTAZOL100MGTABLET / ORAL2004-11-232680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A077019-001CILOSTAZOL50MGTABLET / ORAL2004-11-235bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A077019-002CILOSTAZOL100MGTABLET / ORAL2004-11-235bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A077019-001CILOSTAZOL50MGTABLET / ORAL2004-11-23d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A077019-002CILOSTAZOL100MGTABLET / ORAL2004-11-23d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A077019-001CILOSTAZOL50MGTABLET / ORAL2004-11-23d06236e962d9…
2024-10-29 15:01 UTC2024-10A077019-002CILOSTAZOL100MGTABLET / ORAL2004-11-23d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A077019-001CILOSTAZOL50MGTABLET / ORAL2004-11-2379d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A077019-002CILOSTAZOL100MGTABLET / ORAL2004-11-2379d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A077019-001CILOSTAZOL50MGTABLET / ORAL2004-11-23301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A077019-002CILOSTAZOL100MGTABLET / ORAL2004-11-23301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A077019-001CILOSTAZOL50MGTABLET / ORAL2004-11-231e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A077019-002CILOSTAZOL100MGTABLET / ORAL2004-11-231e350fbaab3a…
2024-05-31 18:47 UTC2024-05A077019-001CILOSTAZOL50MGTABLET / ORAL2004-11-238072bd15b7f6…
2024-05-31 18:47 UTC2024-05A077019-002CILOSTAZOL100MGTABLET / ORAL2004-11-238072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A077019-001CILOSTAZOL50MGTABLET / ORAL2004-11-235c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A077019-002CILOSTAZOL100MGTABLET / ORAL2004-11-235c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A077019-001CILOSTAZOL50MGTABLET / ORAL2004-11-235d02ea3f76ae…
2022-04-08 23:34 UTC2022-04A077019-002CILOSTAZOL100MGTABLET / ORAL2004-11-235d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A077019-001CILOSTAZOL50MGTABLET / ORAL2004-11-234b0b4de00fa7…
2022-04-04 05:41 UTC2022-04A077019-002CILOSTAZOL100MGTABLET / ORAL2004-11-234b0b4de00fa7…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-10-15 13:18:302026-09A077019-001AB1c2088c7a36db…
2026-10-15 13:18:302026-09A077019-002AB1c2088c7a36db…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
CILOSTAZOL
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
CILOSTAZOL50 mg/1

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
84386-002-608438600026060 TABLET in 1 BOTTLE (84386-002-60) 60 tablet2026-09-03NoNoCurrent